CureVac COVID vaccine let-down spotlights mRNA design challenges
نویسندگان
چکیده
Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines.
منابع مشابه
Dengue vaccine design: issues and challenges.
Dengue virus infection is now a global problem affecting tens of millions of people. The spread of the four dengue virus serotypes had led to increased incidence of dengue haemorrhagic fever (DHF) reported and with 2.5 billion people at risk, efforts towards the development of safe and effective vaccines against dengue must be accelerated. This chapter reviews some of the important lessons of p...
متن کاملCoViD, A System for Collaborative Virtual 3D Design
Many important decisions in the design process are made fairly early on, after designers have presented initial concepts. In many domains, these concepts are now realized as 3D digital models and, in meetings, the stakeholders evaluate these potential solutions. Frequently, the participants in such a meeting want to interactively modify the proposed designs to explore the design space better. T...
متن کاملApoptotic cells let down their guard
Unfolding chromatin nets Spiderman doesn’t have anything on neutrophils, which snag microscopic bad guys with webs of chromatin. Wang et al. show that by unfurling chromatin, a histone-modifying protein helps the defensive cells set their traps. During an infection or infl ammation, dying neutrophils spill their DNA to form pathogentrapping NETs (neutrophil extracellular traps). This gooey mate...
متن کاملDown-scaling of Thin-Film Transistors: Opportunities and Design Challenges
With the ever-increasing demands for integration of advanced electronic functions into large-area electronics, down-scaling of thin-film transistors (TFTs) becomes very necessary. The key device operational issues associated with TFT scaling, including short-channel effects (SCEs) and self-heating, are considered in this paper. Device structure engineering approaches are introduced to suppress ...
متن کاملCMAJ Specialty Spotlights
© 1999 Canadian Medical Association or its licensors Technology: Glycoprotein IIb/IIIa receptor antagonists of platelets Use: The activation of platelet glycoprotein IIb/IIIa receptors results in rapid thrombosis through specific binding of its ligand, fibrinogen. The use of the Fab fragment of the mouse/human chimeric monoclonal antibody 7E3, now known as the pharmaceutical abciximab (ReoPro),...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2021
ISSN: ['1476-4687', '0028-0836']
DOI: https://doi.org/10.1038/d41586-021-01661-0